For the year ending 2025-12-31, HALO has $2,525,323K in assets. $2,476,509K in debts. $133,820K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 133,820 | |||
| Marketable securities, available-for-sale | 9,000 | |||
| Accounts receivable, net and contract assets | 441,273 | |||
| Inventories | 176,475 | |||
| Prepaid expenses and other current assets | 64,639 | |||
| Total current assets | 825,207 | |||
| Property and equipment, gross | 77,601 | |||
| Accumulated depreciation and amortization | 33,159 | |||
| Subtotal | 44,442 | |||
| Operating lease right-of-use assets | 37,695 | |||
| Property and equipment, net | 82,137 | |||
| Prepaid expenses and other assets | 53,551 | |||
| Goodwill | 580,360 | |||
| Intangible assets, net | 981,467 | |||
| Deferred tax assets, net | 0 | |||
| Restricted cash | 2,601 | |||
| Total assets | 2,525,323 | |||
| Accounts payable | 20,899 | |||
| Accrued expenses | 156,193 | |||
| Total current liabilities | 177,092 | |||
| Long-term debt, net | 2,142,630 | |||
| Other long-term liabilities | 113,863 | |||
| Deferred tax liabilities, net | 42,924 | |||
| Total liabilities | 2,476,509 | |||
| Common stock - 0.001 par value 300,000 shares authorized 117,782 and 123,138 shares issued and outstanding as of december31, 2025 and 2024, respectively | 118 | |||
| Additional paid-in capital | 12,002 | |||
| Accumulated other comprehensive (loss) income | -18,092 | |||
| Retained earnings | 54,786 | |||
| Total stockholders equity | 48,814 | |||
| Total liabilities and stockholders equity | 2,525,323 | |||
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)